Marshall Wace
ZYME icon

Marshall Wace’s Zymeworks ZYME Stock Holding History

Marshall Wace’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$807K Buy
+32,223
New +$762K ﹤0.01% 2229
2025
Q4 		– Sell
-154,858
Closed -$2.64M – 3585
2025
Q3 		$2.64M Buy
+154,858
New +$2.22M ﹤0.01% 1481
2024
Q4 		– Sell
-209,765
Closed -$2.63M – 3072
2024
Q3 		$2.63M Buy
+209,765
New +$2.28M ﹤0.01% 1260
2022
Q3 		– Sell
-21,943
Closed -$117K – 3876
2022
Q2 		$117K Sell
21,943
-39,792
-64% -$241K ﹤0.01% 3260
2022
Q1 		$405K Buy
+61,735
New +$550K ﹤0.01% 2866
2021
Q2 		– Sell
-9,933
Closed -$314K – 3172
2021
Q1 		$314K Buy
+9,933
New +$404K ﹤0.01% 2116
2020
Q4 		– Sell
-18,157
Closed -$846K – 2242
2020
Q3 		$846K Sell
18,157
-52,605
-74% -$1.81M 0.01% 1086
2020
Q2 		$2.55M Buy
+70,762
New +$2.61M 0.02% 701
2020
Q1 		– Sell
-821
Closed -$37K – 2127
2019
Q4 		$37K Sell
821
-5,662
-87% -$206K ﹤0.01% 1568
2019
Q3 		$161K Buy
+6,483
New +$162K ﹤0.01% 1321
2019
Q2 		– Sell
-55,720
Closed -$902K – 1916
2019
Q1 		$902K Buy
+55,720
New +$864K 0.01% 964

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Marshall Wace's ZYME Position: Q1 2026 in Review

Marshall Wace opened a new position in Zymeworks (ZYME) in Q1 2026: 32,223 shares worth $807K. The stake represents ﹤0.01% of the portfolio and ranks #2229 among its holdings. This is a return to the name: Marshall Wace previously reported a position in ZYME as recently as Q3 2025.

Marshall Wace first reported a position in ZYME in Q1 2019 and has held it in 11 quarters since. The position peaked at $2.64M in Q3 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Marshall Wace held 32,223 shares of Zymeworks worth $807K as of Q1 2026.
  • Zymeworks was a new Marshall Wace position in Q1 2026.
  • Zymeworks made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2229 holding.
  • Marshall Wace first reported a position in Zymeworks in Q1 2019 and has held it in 11 quarters since.
  • Marshall Wace's Zymeworks position peaked at $2.64M in Q3 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.